ABCD Announcements
 |
CREDENCE - Primary renal outcome benefit demonstrated with Canagliflozin 100mg . Published in NEJM April 14th 2019Peter Winocour (Chairman ABCD, 2008-2011)Tuesday, 23rd April 2019 Abstract of published paper: In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg... Read More |
 |
Launch of the ABCD nationwide semaglutide audit at Diabetes UKDr Bob Ryder (Website Co-ordinator, Clinical Lead, ABCD Nationwide Audits)Thursday, 7th March 2019 Today at Diabetes UK, ABCD is pleased to announce the full launch of the nationwide semaglutide audit. As you will know, the clinical trials with semaglutide suggest that it is more effective than the other GLP-1 receptor agonists that we have to... Read More |
 |
ABCD nationwide FreeStyle Libre audit shows improved diabetes control in people with Type 1 diabetes during the first 6 months of usageEmma Wilmot, Chair, Diabetes Technology NetworkThursday, 7th March 2019 Press release: Association of British Clinical Diabetologists (ABCD) nationwide audit of the FreeStyle Libre Flash Glucose Monitoring System (Abbott Laboratories) shows improved diabetes control in people with Type 1 diabetes during... Read More |
 |
Release of “Consensus position statement for Remission of Type 2 diabetes", prepared jointly with Primary Care Diabetes SocietyDr Dinesh Nagi, Chair ABCD CommitteeMonday, 4th March 2019 ABCD is delighted to announce the release of “Consensus position statement for Remission of Type 2 diabetes, prepared jointly with Primary Care Diabetes Society” We understand the importance of this consensus definition and have... Read More |
 |
Diabetes patient groups call on Government to reassure patients on post-Brexit insulin supplyDr Chris Walton (ex Officio Chairman)Thursday, 21st February 2019 Two patient groups representing people with diabetes, Diabetes UK and the Juvenile Diabetes Research Foundation (JDRF) have issued a joint statement calling on the Government to present ‘concrete detail’ on its plans to guarantee supply of... Read More |
|
|
The ASK StudyDr Bob Ryder (Website Co-ordinator, Clinical Lead, ABCD Nationwide Audits)Tuesday, 5th February 2019 We would kindly ask you to participate in The ASK Study, a collaborative study of King's College London (UK) and Leeds Beckett University (UK). The ASK Study is an online questionnaire which explores beliefs about obesity,... Read More |
 |
Help us plan future JBDS documentsDr. Umesh Dashora, ABCD Co-opted - News editor, BJDTuesday, 5th February 2019 We are inviting colleagues to help us plan future JBDS documents by completing a short questionnaire. Many thanks to everyone who has fed back already. |
 |
Best Inpatient Diabetes Educational Programme for Health Care ProfessionalsProfessor Mike Sampson (Chair JBDS-IP)Thursday, 31st January 2019 We are inviting colleagues to submit entries to this year’s competition which will be for the: ‘Best Inpatient Educational Diabetes Programme for Health Care Professionals’ This JBDS – IP project is being led by Umesh Dashora, Debbie... Read More |
|
|
Increasing the uptake of new technologies in diabetes: Recommended ActionsDinesh Nagi, Chair ABCDWednesday, 16th January 2019 An ABCD workshop looked at what are the barriers to wider adoption of technology in diabetes and how these could be overcome, with a focus on actions that could be taken forward by stakeholders. Read the report now... |
|
|
ABCD nationwide FreeStyle Libre audit first data deadline passes successfully – now the audit continuesDr Bob Ryder (Website Co-ordinator, Clinical Lead, ABCD Nationwide Audits)Thursday, 20th December 2018 We wish to thank all those who worked so hard to submit data in time for our first deadline, and we are pleased to inform you that we had 216 users from 127 sites in 100 centres contributing data on 2869 patients. Analyses are now being... Read More |
 |
Diabetes UK warns of increasing number of children and young adults with Type 2 DiabetesDr Ansu Basu ABCD Elected Committee MemberWednesday, 5th December 2018 Diabetes UK has published a new analysis highlighting that 6,836 children and young adults are reported to have Type 2 diabetes in England and Wales. This figure is far higher than the 715 children and young people under the age of 25 receiving... Read More |
|
|
RCP council representationDinesh Nagi, Chair ABCDFriday, 30th November 2018 I am delighted to announce that Dr Robert Gregory, Consultant in Diabetes and Endocrinology at Leicester Royal Infirmary, has been unanimously chosen to represent the three societies on the RCP council. Dr Gregory takes over from... Read More |
|
|
NHS England announces action to reduce variation in access to flash glucose monitoringEmma Wilmot, Chair, Diabetes Technology NetworkThursday, 29th November 2018 Simon Stevens, the Chief Executive of NHS England has announced that from April 2019, all patients who qualify for access to the flash glucose monitoring device, FreeStyle Libre, will be able to receive it on prescription from their local GP or... Read More |
 |
Drugs used in diabetes now make up 11.4% of total primary care net ingredient costsAna Pokrajac (ABCD Committee Member and Diabetes UK National Clinical Champion)Wednesday, 14th November 2018 NHS England have published their latest data on the prescriptions issued in primary care and dispensed in the community in the treatment of diabetes. The report finds that drugs used in diabetes now make up 11.4% of total primary care net... Read More |
|
|
Understanding Diabetes Campaign LaunchesDinesh Nagi, Chairman ABCDWednesday, 14th November 2018 We recently worked with Mediaplanet UK on the 2018 Understanding Diabetes Campaign. A printed publication was enclosed within every copy of The Guardian newspaper and the content available online also at http://www.diabetesadvice.co.uk/... Read More |
|
|
Rowan Hillson Inpatient Safety Award 2018Professor Mike Sampson (Chair JBDS-IP)Thursday, 1st November 2018 We are inviting colleagues to submit entries to this years competition which will be for the ‘Best Inpatient Educational Diabetes Programme for Health Care Professionals. This JBDS – IP project is being led by Umesh Dashora, Debbie... Read More |
|
|
ABCD nationwide audit at the EASDDr Bob Ryder (Website Co-ordinator, Clinical Lead, ABCD Nationwide Audits)Monday, 15th October 2018 Poster 1, poster 2 and interview. Two posters from the ABCD nationwide audit programme were presented at the EASD in Berlin between 2nd and 5th October 2018. Dr Amar Puttanna presented data from the canagliflozin audit looking at the impact of... Read More |
 |
Latest data on EndoBarrier treatment from the EASDDr Chris Walton (ex Officio Chairman)Monday, 15th October 2018 ePoster and interview. In the wake of the two studies with EndoBarrier sponsored by ABCD (click here) Dr Bob Ryder established an NHS service to give EndoBarrier treatment in 2014 and 62 EndoBarriers were implanted as part of this. At the... Read More |
|
|
NICE impact report on diabetesDinesh Nagi, Chair ABCDFriday, 28th September 2018 NICE has published a new impact report on diabetes. This explores how NICE guidence has been implemented by the healthcare system and what progress has been made to improve outcomes for those with diabetes or at risk of developing... Read More |
|
|
NICE medical technology guidance publication: Neuropad for detecting preclinical diabetic peripheral neuropathyDinesh Nagi, Chairman ABCDWednesday, 12th September 2018 The final NICE medical technologies guidance on Neuropad for detecting preclinical diabetic peripheral neuropathy has been published. You can find the guidance on the NICE website here: https://www.nice.org.uk/guidance/mtg38 |
Information for HCPs
ABCD Webinar Series
